|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB and Mason AC: Rising incidence
of hepatocellular carcinoma in the United States. N Engl J Med.
340:745–750. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tamguney T and Stokoe D: New insights into
PTEN. J Cell Sci. 120:4071–4079. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Martin J and Dufour JF: Tumor suppressor
and hepatocellular carcinoma. World J Gastroenterol. 14:1720–1733.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yao YJ, Ping XL, Zhang H, et al:
PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene.
18:3181–3185. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Steck PA, Pershouse MA, Jasser SA, et al:
Identification of a candidate tumour suppressor gene, MMAC1, at
chromosome 10q23.3 that is mutated in multiple advanced cancers.
Nat Genet. 15:356–362. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee Y, Kim M, Han J, et al: MicroRNA genes
are transcribed by RNA polymerase II. EMBO J. 23:4051–4060. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xie X, Lu J, Kulbokas EJ, et al:
Systematic discovery of regulatory motifs in human promoters and 3′
UTRs by comparison of several mammals. Nature. 434:338–345.
2005.
|
|
9
|
Mendell JT: miRiad roles for the miR-17-92
cluster in development and disease. Cell. 133:217–222. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiao C, Srinivasan L, Calado DP, et al:
Lymphoproliferative disease and autoimmunity in mice with increased
miR-17-92 expression in lymphocytes. Nat Immunol. 9:405–414. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Slipicevic A, Holm R, Nguyen MT, Bohler
PJ, Davidson B and Florenes VA: Expression of activated Akt and
PTEN in malignant melanomas: relationship with clinical outcome. Am
J Clin Pathol. 124:528–536. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kerr JF, Winterford CM and Harmon BV:
Apoptosis. Its significance in cancer and cancer therapy. Cancer.
73:2013–2026. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu Z, Stokoe D, Kane LP and Weiss A: The
inducible expression of the tumor suppressor gene PTEN promotes
apoptosis and decreases cell size by inhibiting the PI3K/Akt
pathway in Jurkat T cells. Cell Growth Differ. 13:285–296.
2002.PubMed/NCBI
|
|
14
|
Smith JS and Jenkins RB: Genetic
alterations in adult diffuse glioma: occurrence, significance, and
prognostic implications. Front Biosci. 5:D213–D231. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang YS, Dai Y, Yu XF, et al: Microarray
analysis of microRNA expression in hepatocellular carcinoma and
non-tumorous tissues without viral hepatitis. J Gastroenterol
Hepatol. 23:87–94. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang GL, Zhang XH, Guo GL, et al:
Expression of microRNA-21 in invasive ductal carcinoma of the
breast and its association with phosphatase and tensin homolog
deleted from chromosome expression and clinicopathologic features.
Zhonghua Yi Xue Za Zhi. 88:2833–2837. 2008.
|
|
18
|
Fang J, Ding M, Yang L, Liu LZ and Jiang
BH: PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
Cell Signal. 19:2487–2497. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mann CD, Neal CP, Garcea G, Manson MM,
Dennison AR and Berry DP: Prognostic molecular markers in
hepatocellular carcinoma: a systematic review. Eur J Cancer.
43:979–992. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
O’Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005.PubMed/NCBI
|
